Abstract
Purpose: To assess the regulations for Preimplantation Genetic Diagnosis (PGD). How to regulate and control PGD. Is any special licensing procedure necessary?
Methods: A review of the statements of the organization and the Japan Society of Obstetrics and Gynecology (JSOG). Also, we assess the JSOG guidelines for PGD and the statements on diagnosis of genetic diseases of the Japan Society of Human Genetics. We discuss extra licenses and qualifications for laboratories, staff, and directors.
Results: At present, there are no regulations governing PGD for laboratories, scientists, directors, and staff. Regulations are set by committees and organizations of the countries involved. We don't have any worldwide system of controls. In Japan, we are considering regulations in the fields of reproduction and genetics.
Conclusions: PGD requires high-level techniques in taking samples, and high-level knowledge about genetic diseases. In diagnosis, we have to be as close to 100% accurate as possible. However, samples for PGD are so small that there is always a risk of failure. Also, we are required to have highly specialized knowledge about reproduction and genetics. In Japan, JSOG has a plan to join with the Society for Investigating Infertility and Society for Genetics.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Handyside A, Kontogianni E, Hardy K, Wimston R: Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature 1990;344:768-770.
Munne S, Lee A, Rosenwaks Z, Grifo J, Cohen J: Diagnosis of major chromosome aneuploidies in human preimplantation embryos. Hum Reprod 1993;8:2185-2191.
ESFRE PGD Consortium Steering Committee. ESHRE Preimplantation Genetic Diagnosis Consortium: Data collection III (May 2001). Hum Reprod 2002;17:233-246.
Griffin DK, Wilton LJ, Handyside AH, Atkinson G, Winston RML, Delhanty JDA: Diagnosis sexi in preimplantation embryos by fluorescence in situ hybridization. BMJ 1993.
Staessen C, Van Assche E, Joris H, Bonduelle M, Vandervorst M, Liebaers I, Van Steirteghem A: Clinical experience of sex determination by fluorescent in situ hybridization for preimplantation genetic diagnosis. Mol Hum Reprod 1999;5:382-389.
Verlinsky Y, Eviskov S: Karyotyping of human oocytes by chromosomal analysis of the second polar body. Mol Hum Reprod 1999;5:89-96.
Statement of Japan Society of Obstetrics and Gynecology: Acta Obstet Gynaecol Jpn 1999;51:15-43.
Guideline of Japan Society of Human Genetics for diagnosis of genetic disease, 1996.
Guideline of Japan Society of Human Genetics for program for education for a specialist for genetics, 1998.
Guideline of Japan Society of Obstetrics and Gynecology for reiteration, 1981.
Guideline of Japan Society of Obstetrics and Gynecology—The number of institutions which have performed or registered IVF-ET-, 2000.
Statement of Japan Society for Fertility and Sterility. 1996; Guideline of Japan Society of Fertility and Sterility.
The First Meeting of Reproduction and Genetic Counseling. 2001, Tokyo.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Takeshita, N., Kubo, H. Regulating Preimplantation Genetic Diagnosis—How to Control PGD. J Assist Reprod Genet 21, 19–25 (2004). https://doi.org/10.1023/B:JARG.0000017230.12954.90
Issue Date:
DOI: https://doi.org/10.1023/B:JARG.0000017230.12954.90